Amgen’s Imlygic
A new method to target melanoma that was just approved by the FDA could be an important first step in transforming the way we treat many cancers.
The treatment is called Imlygic,and it uses a virus to kill skin cancer cells, while leaving healthy cells alone. It’s not terribly effective yet, and it’s still in the early stages. Yet researchers are excited about the new approach: It’s the first virus-based cancer treatment that’s gotten a stamp of approval from the FDA.
And the applications could reach beyond melanoma.
Rebecca Harrington 